These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 35459617)

  • 41. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
    Ben Jehuda R; Shemer Y; Binah O
    Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
    Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
    Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRISPR/Cas9 Genome Editing Approaches for Psychiatric Research.
    Gutiérrez-Rodríguez A; Cruz-Fuentes CS; Genis-Mendoza AD; Nicolini H
    Braz J Psychiatry; 2023 May; 45(2):137-145. PubMed ID: 36753615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models.
    Kaindl J; Winner B
    Curr Top Behav Neurosci; 2019; 42():159-183. PubMed ID: 31407242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR/Cas9-Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells.
    Sharma A; Toepfer CN; Ward T; Wasson L; Agarwal R; Conner DA; Hu JH; Seidman CE
    Curr Protoc Hum Genet; 2018 Jan; 96():21.11.1-21.11.20. PubMed ID: 29364519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
    Lee CT; Bendriem RM; Wu WW; Shen RF
    J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New considerations for hiPSC-based models of neuropsychiatric disorders.
    Hoffman GE; Schrode N; Flaherty E; Brennand KJ
    Mol Psychiatry; 2019 Jan; 24(1):49-66. PubMed ID: 29483625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
    Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R
    Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
    Getachew H; Chinchilla B; Fernandez-Godino R
    Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models.
    Sebastian R; Song Y; Pak C
    Schizophr Res; 2022 Jul; ():. PubMed ID: 35835709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
    Zhang Y; Karakikes I
    Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones.
    Smith RH; Chen YC; Seifuddin F; Hupalo D; Alba C; Reger R; Tian X; Araki D; Dalgard CL; Childs RW; Pirooznia M; Larochelle A
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33322084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.
    Brookhouser N; Raman S; Potts C; Brafman DA
    Cells; 2017 Feb; 6(1):. PubMed ID: 28178187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
    Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
    Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining Off-flow, a Nextflow-coded program, and whole genome sequencing reveals unintended genetic variation in CRISPR/Cas-edited iPSCs.
    Shum C; Han SY; Thiruvahindrapuram B; Wang Z; de Rijke J; Zhang B; Sundberg M; Chen C; Buttermore ED; Makhortova N; Howe J; Sahin M; Scherer SW
    Comput Struct Biotechnol J; 2024 Dec; 23():638-647. PubMed ID: 38283851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple genes in a single GWAS risk locus synergistically mediate aberrant synaptic development and function in human neurons.
    Zhang S; Zhang H; Forrest MP; Zhou Y; Sun X; Bagchi VA; Kozlova A; Santos MD; Piguel NH; Dionisio LE; Sanders AR; Pang ZP; He X; Penzes P; Duan J
    Cell Genom; 2023 Sep; 3(9):100399. PubMed ID: 37719141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
    Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
    Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells.
    Hong Y; Yang Q; Song H; Ming GL
    Mol Psychiatry; 2023 Apr; 28(4):1430-1439. PubMed ID: 36782062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing.
    Bonnycastle LL; Swift AJ; Mansell EC; Lee A; Winnicki E; Li ES; Robertson CC; Parsons VA; Huynh T; Krilow C; Mohlke KL; Erdos MR; Narisu N; Collins FS
    CRISPR J; 2024 Feb; 7(1):53-67. PubMed ID: 38353623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.